BW
CNMD icon

Bravera Wealth’s CONMED CNMD Stock Holding History

Bravera Wealth’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9
Closed -$365 – 434
2025
Q4 		$365 Buy
+9
New +$392 ﹤0.01% 478

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Bravera Wealth's CNMD Position: Q1 2026 in Review

Bravera Wealth sold out of CONMED (CNMD) in Q1 2026, closing a stake of 9 shares — an estimated $365 sold.

Bravera Wealth first reported a position in CNMD in Q4 2025 and held it in 1 quarter. The position peaked at $365 in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Bravera Wealth reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Bravera Wealth sold 9 CONMED shares in Q1 2026, an estimated $365.
  • Bravera Wealth first reported a position in CONMED in Q4 2025 and held it in 1 quarter.
  • Bravera Wealth's CONMED position peaked at $365 in Q4 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Bravera Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.